[opensourcepharma] rare disease startups and patient orgs

Mon Dec 28 16:43:01 UTC 2015

Some possible lessons to be learned from the rare disease field, or allies to be gained.   Some inapplicability too, as the approaches are quite different.

There was also that idea from Bellagio of the world's first open source pharma company.....with immutable affordable pricing structures baked in.

Happy New Year to all...

Jaykumar

http://www.nytimes.com/2015/12/26/your-money/parents-of-children-with-rare-diseases-find-hope-in-for-profit-companies.html?<http://www.nytimes.com/2015/12/26/your-money/parents-of-children-with-rare-diseases-find-hope-in-for-profit-companies.html?mabReward=CTM&moduleDetail=recommendations-0&action=click&contentCollection=Magazine&region=Footer&module=WhatsNext&version=WhatsNext&contentID=WhatsNext&src=recg&pgtype=article>

Jaykumar Menon, J.D., M.I.A.
Professor of Practice
McGill University Institute for the Study of International Development
[McGill ISID logo small]
Peterson Hall, Room 128
3460 McTavish Street
Montreal, Quebec H3A 0E6

Research Fellow
Centre for International Sustainable Development Law

Tel: 514-398-3507
Fax:  514-398-8432
North America mobile:  +1-917-302-0722
Email:  jaykumar.menon at mcgill.ca <mailto:jaykumar.menon at mcgill.ca>
Skype:  jmenon1
Viber:  917 302 0722
India mobile:  +91 704 506 2482

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.okfn.org/pipermail/opensourcepharma/attachments/20151228/33a576ac/attachment.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image001.jpg
Type: image/jpeg
Size: 2995 bytes
Desc: image001.jpg
URL: <http://lists.okfn.org/pipermail/opensourcepharma/attachments/20151228/33a576ac/attachment.jpg>